Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA

Trieu, Lisa; Proops, Douglas C.; Ahuja, Shama D.

doi:10.3201/eid2103.141313

i

Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA

Supporting Files Public Domain

Mar 2015
By Trieu, Lisa ; Proops, Douglas C. ; Ahuja, Shama D.

File Language:

English

Details

Alternative Title:

Emerg Infect Dis
Personal Author:

Trieu, Lisa ; Proops, Douglas C. ; Ahuja, Shama D.
Description:

Contacts of persons infected with multidrug-resistant tuberculosis (MDR TB) have few prophylaxis options. Of 50 contacts of HIV- and MDR TB-positive persons who were treated with moxifloxacin, 30 completed treatment and 3 discontinued treatment because of gastrointestinal symptoms. Moxifloxacin was generally well-tolerated; further research of its efficacy against MDR TB is needed.
Subjects:

Antibiotic Prophylaxis Antitubercular Agents Coinfection Fluoroquinolones Follow-Up Studies Hiv Infections Humans Moxifloxacin Mycobacterium Tuberculosis Treatment Outcome Tuberculosis, Multidrug-Resistant
Source:

Emerg Infect Dis. 21(3):500-503.
Document Type:

Journal Article
Place as Subject:

New York City, NY
Volume:

21
Issue:

3
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

urn:sha256:4d0c01119d0a4866ad36eb415ae78d523d2d263b325169a2227371f09740c77d
Download URL:

https://stacks.cdc.gov/view/cdc/28107/cdc_28107_DS1.pdf
File Type:

[PDF - 1.22 MB ]

14-1313.nxml

Download txt
license.txt

Download txt

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.